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Objective: Prolonged mechanical ventilation after cardiac surgery is a serious complication that warrants search
for new treatment strategies. Our objective was to identify patients still requiring mechanical ventilation 3 days
after the operation and those successfully weaned by day 10 to avoid needless and potentially hazardous inter-
ventions, such as tracheostomy.
Methods: All consecutive patients still mechanically ventilated on day 3 after cardiac surgery were included in
a prospective observational cohort. Patients’ preoperative, intraoperative, and postoperative data were recorded.
Logistic regression analysis was used to identify factors associated with successful weaning from mechanical
ventilation by postoperative day 10.
Results: Among 2620 patients who underwent cardiac surgery, 163 were still receiving ventilatory assistance on
day 3. By day 10, 50 (31%) patients had been successfully weaned, 78 (48%) were still receiving mechanical
ventilation, and 35 (21%) had died. Multivariable regression analysis retained 6 day-3 factors associated with
successful weaning (odds ratio): urine output 500 mL/24 hours or greater (16.47), Glasgow coma score of 15
(9.75), arterial bicarbonates 20 mmol/L or greater (6.09), platelet count 100 g/L or greater (3.18), patients without
inotropic support with epinephrine/norepinephrine (2.84), and absence of lung injury (2.40). The area under the
receiver operating characteristics curve for the simple score based on this model’s b-coefficients was 0.84 (95%
confidence intervals, 0.78–0.91). Depending on the threshold chosen for this scoring system, only 3% to 17% of
the patients would have received a needless intervention.
Conclusions: A simple score based on postoperative day-3 physiologic parameters might help intensivists early
identify patients with a strong likelihood of success in rapid weaning from mechanical ventilation and therefore
prevent needless procedures aimed at reducing duration of mechanical ventilation and related complications.Patients undergoing cardiac surgery are generally able to
resume spontaneous ventilation as soon as they have recov-
ered from the anesthesia. However, approximately 2.6% to
22.7% of them require prolonged mechanical ventilation
(MV), depending on the threshold selected to define pro-
longed MV.1-7 For these latter patients, in-hospital mortality
can exceed 40%.7 MV duration and length of hospital stay
can reach or exceed 2 to 3 weeks,1,4 with a major economic
impact and consequences on quality of life.5,8 In one study,
effective cost per survivor was 18 times higher for patients
mechanically ventilated for more than 4 days than for
weaned patients.3 In another study, the extubation-failure
group consumed 37% of patient-days in intensive care
unit (ICU) care.9
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doi:10.1016/j.jtcvs.2009.05.034948 The Journal of Thoracic and Cardiovascular SuNew interventions or treatment strategies are desirable to
improve the outcomes of this specific group of patients. For
example, early percutaneous tracheotomy, which has been
shown to shorten MV duration and lower mortality in pa-
tients in the ICU, might be beneficial in such situations.10-13
However, ICU physicians’ prediction for MV weaning is
manifestly inaccurate14 and, to date, no clinical test or scor-
ing system has been able to correctly identify patients for
whom MV duration will be prolonged and therefore these
interventions might be beneficial. Additionally, performing
interventions such as tracheostomy in patients with a high
probability of rapid and successful weaning might at best
be useless and at worst be associated with severe complica-
tions. Therefore, the objective of this study was to evaluate
patients still receiving MV 3 days after heart surgery. We
wanted to identify those with a strong likelihood of rapid
MV weaning success, within the 10 postoperative days, to
avoid needless interventions aimed at reducing MV dura-
tion, such as early tracheostomy.
PATIENTS AND METHODS
This study was conducted in accordance with the ethical standards of our
hospital’s Committee for the Protection of Human Subjects. Informed con-
sent was not required because this observational study did not modify exist-
ing diagnostic or therapeutic strategies.rgery c October 2009
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MAbbreviations and Acronyms
CABG ¼ coronary artery bypass graft
ECMO ¼ extracorporeal membrane
oxygenation
FIO2, ¼ fraction of inspired oxygen
ICU ¼ intensive care unit
MV ¼ mechanical ventilation
PaO2 ¼ partial pressure of arterial oxygen
SAPS II ¼ simplified acute physiology score
SOFA score ¼ sepsis-related organ failure score
Study Population
Between October 2004 and January 2006, all consecutive patients older
than 18 years, who had undergone cardiac surgery and were still receiving
MV 48 hours later or who had been reintubated before the 96th hour, that is,
were on MV on postoperative day 3, were enrolled in this prospective study
conducted in a single cardiothoracic surgical ICU in a university hospital.
Patients were excluded from this study (1) if they had died within the first
3 postoperative days, (2) if they required MV more than 48 hours before sur-
gery or mechanical circulatory assistance before surgery, or (3) if an artifi-
cial heart (i.e, CardioWest [SynCardia Systems, Inc, Tucson, Ariz] or
HeartMate [Thoratec Corporation, Pleasanton, Calif]) was implanted. On
the other hand, patients were included if extracorporeal membrane oxygen-
ation (ECMO) was used temporarily after cardiac surgery, including heart
transplantation.
ICU Management
At the end of the operation, patients were admitted directly to the cardio-
thoracic ICU. Initial hemodynamic management (adequate volume therapy,
inotropes, and/or vasopressors) was tailored to patients’ status and type of
operation. Hemodynamic status was controlled continuously with an arterial
catheter for all patients and a pulmonary artery catheter in the case of hemo-
dynamic instability. The patients were ventilated by the volume-assist con-
trol mode with a tidal volume of 8 to 10 mL/kg predicted body weight. The
fraction of inspired oxygen (FIO2) and respiratory rate adjustments were
made according to routine blood-gas analyses to maintain partial pressure
of arterial oxygen (PaO2) between 80 and 100 mm Hg and partial pressure
of arterial carbon between 35 and 40 mm Hg. Postoperative sedation with
sufentanil and midazolam was adjusted to achieve a sedation level at which
the patient responds to gentle shaking, corresponding to a Ramsay sedation
score of 4 or 3. Patients were tested for tracheal extubation within 6 hours of
arrival in the ICU, aiming for systolic blood pressure greater than 100 mm
Hg, pulse rate less than100 beats/min, and no or low-dose vasoconstrictive
drugs. Blood loss had to be less than 100 mL/h, with a trend toward
decreased fluid drainage from chest drains. The decision to extubate a patient
was left to the independent discretion of the consulting anesthetist, usually
after a trial of spontaneous breathing or a trial under low-level pressure sup-
port. However, before extubation, the patient had to be neurologically alert
and oriented, able to move equally all four limbs, breathe spontaneously,
and obey commands.
Data Collection
A specific chart was constituted prospectively. Day 1 corresponded to
the day of surgery. All of the following parameters were recorded preoper-
atively: age; sex; body mass index; chronic respiratory insufficiency,
defined as maximal expiratory flow volume/second less than 75% of the
theoretical value or continuous treatment with a b2 mimetic, corticosteroids,
or history of MV; chronic renal insufficiency defined as the need for extra-
renal dialysis; diabetes mellitus if the patient was receiving insulin at home;The Journal of Thoracic and Cand comorbidity scores, that is, scores devised by McCabe and Jackson15
and Charlson and associates16; New York Heart Association class; left ven-
tricular ejection fraction less than 50%; European system for cardiac oper-
ative risk evaluation (EuroSCORE)17; and elective or emergency surgery.
Intraoperative factors were as follows: type of surgery classified in five
categories: (1) coronary artery bypass graft (CABG), (2) valve surgery,
(3) CABGþvalve surgery, (4) transplantation, and (5) miscellaneous (cor-
responding mainly to aortic dissection or aortic aneurysm and sometimes
pericardectomy, myxoma, or ventricular aneurysm); cardiopulmonary
bypass and aortic crossclamp times, use of an intra-aortic balloon pump,
ECMO use; and troponin I level the day after the operation.
Postoperative parameters recorded on postoperative day 3 were as fol-
lows: simplified acute physiology score (SAPS) II,18 recording the worst
value for the parameters, sepsis-related organ failure (SOFA) score,19 and
some dichotomized clinical biological and radiologic parameters usually
taken into account in scores such as SOFA score or lung injury score and
Murthy radiologic score,20 with cutoffs corresponding to those routinely
reported to describe severe status (ie, Glasgow coma score less than 15
[evaluated for a patient still receiving intravenous sedation or not], lung
injury defined by the association of PaO2/FIO2 ratio less than 200, and radio-
logic pulmonary abnormalities in at least two quadrants, use of epinephrine
or norepinephrine at any dose, oligo-anuria [urine output< 500 mL/24
hours]; less than 100 3 109 platelets/L, and arterial bicarbonates less than
20 mmol/L. SAPS II on day 3 was also dichotomized according to the
median value for the cohort.
The evaluation period was defined as the 7 days after postoperative day 3
(ie, postoperative day 10): the patient was either alive and off MV, defining
the successfully weaned group, or MV-dependent or dead, defining the
failed-weaning group.
The following outcome parameters were also recorded: MV duration, length
of ICU stay, in-hospital mortality, and mortality on postoperative day 30.
Statistical Analysis
The analyses compared the group of patients successfully weaned by day
10 with those who either died or remained MV-dependent at postoperative
day 10 (failed-weaning group). Results are expressed as the means  stan-
dard deviation (SD) or n (%), as appropriate. All statistical analyses were
performed with values available on day 3. We used the Student t test or
the Mann–Whitney U test, when the distribution was not normal, to com-
pare continuous variables, and the c2 test or Fisher’s exact test to compare
percentages, as appropriate.
Univariable analysis was used to identify parameters associated with
successful MV weaning. Thereafter, a stepwise multivariable logistic
regression analysis was used to determine factors independently associated
with weaning success, as defined above. Variables were entered into the
model when they were associated with the weaning outcome, based on a uni-
variable analysis significance threshold of P<.10. Odds ratio and 95% con-
fidence intervals were calculated. The final model was constructed by
backward elimination of nonsignificant variables. The Statistical Package
for the Social Sciences (SPSS, version 10.0, Chicago, Ill) was used to
analyze data.
Thereafter, to derive a simple practical predictive score, the regression b-
coefficients of each significant factor were rounded to the nearest integer
and divided by 2 for simplification. The discriminative performance of
this score to predict weaning failure (MV duration  10 days or death)
was evaluated with receiver operating characteristics curves and quantified
by calculating the area under the curve and 95% confidence intervals. For
each score threshold, sensitivity, specificity, positive and negative predic-
tive values, and likelihood ratios were calculated using standard methods.
RESULTS
A total of 2620 patients underwent cardiac surgery during
the study period. Among them, 163 (6.2%) fulfilled studyardiovascular Surgery c Volume 138, Number 4 949
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Mentry criteria, as all were still receiving MV 3 days after the
operation (Figure 1). Fifty (30.7%) of them were success-
fully weaned and alive on postoperative day 10; none of these
patients was reintubated up to postoperative day 30. On day
10, 78 (48%) were alive but still supported by MV and 35
(21%) had died since day 3. Day-30 and in-hospital mortality
were 33% and 42%, respectively. The baseline characteris-
tics and main outcome information of the study cohort are
given in Table 1. Among the 163 patients studied (mean
age 64  15 years), 26 had undergone CABG, 44 valve sur-
gery, 22 combined CABGþvalve surgery, 34 had received
a heart transplant, and 37 had benefited from other cardiac
and aortic procedures. Although the differences did not reach
statistical significance, rates of successful weaning were
higher after isolated CABG or valve surgery than after com-
bined CABGþvalve surgery, 35% and 39% versus 18%,
respectively. Univariable analysis of factors associated
with successful weaning is shown in Table 2. No statistically
significant difference existed between the 2 groups regarding
preoperative and intraoperative parameters. Alternatively,
organ failure and disease severity markers and scores (lung
injury, inotropic support, kidney injury, SOFA, and SAPS
II) evaluated on postoperative day 3 were significantly less
altered in patients successfully weaned on day 10. Last,
among the 78 patients still mechanically ventilated on day
10, 46 underwent a percutaneous tracheostomy (18  6
days on average after surgery). Day-30 postoperative mortal-
ity tended to be higher for nontracheostomized patients
(34.4% vs 15.2%; P¼ .07). However, in-hospital mortality
rates were not statistically different: 19 (41.3%) of 46 versus
15 (46.9%) of 32 for tracheostomized and nontracheostom-
ized patients, respectively.
Multivariable logistic regression analysis retained the fol-
lowing six independent factors, all recorded on postopera-
tive day 3 and associated with weaning success on day 10
(Table 3): urinary output of 500 mL/24 h or more, arterial
bicarbonates of 20 mmol/L or more, Glasgow coma score
of 15, platelets count of 100 g/L or more, patients without
inotropic support with epinephrine or norepinephrine, and
absence of lung injury. According to their b-coefficient
values, each variable was allocated points as follows: 3 for
urinary output of 500 mL/24 h or more, 2 for arterial bicar-
bonate level of 20 mmol/L or more; 1 for Glasgow coma
score of 15; 1 for platelet count of 100 g/L or more, 1 for
patient without inotropic support with epinephrine or norepi-
nephrine, and 1 for the absence of lung injury. The perfor-
mance of this scoring system, as assessed by the receiver
operating characteristics curve, is shown in Figure 1. The
area under the curve was 0.84 (95% confidence intervals,
0.78–0.91). Positive and negative predictive values and like-
lihood ratios for predicting weaning success by day 10 are
reported in Table 4. Successful MV weaning score of
7 points or more yielded optimal sensitivity, specificity, pos-
itive and negative predictive values, and overall accuracy:950 The Journal of Thoracic and Cardiovascular Sur74%, 79%, 61%, 87%, and 77%. With this scoring system,
a needless tracheostomy would have been performed for
only 3%, 5%, 13%, and 17% of patients whose total score
was less than 5, 6, 7, and 8, respectively.
DISCUSSION
Prolonged MV and ICU stays after cardiac operations are
becoming more and more common, as patients referred for
heart surgery have ever poorer risk profiles with more
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FIGURE 1. Receiver operating characteristics curve for predicting wean-
ing failure with an additive score composed of urinary output of 500mL/
24hours or more (3 points) þ arterial bicarbonate level of 20mmol/L or
more (2 points)þGlasgow coma score of 15 (1 point)þ platelet count of
100g/L or more (1 point),þ no epinephrine or norepinephrine (1 point)þ
no lung injury (1 point). Stars with numbers to the right correspond to dif-
ferent score thresholds. All score parameters were recorded on day 3 after
cardiac surgery.
TABLE 1. Characteristics of 163 study cohort patients requiring MV
on day 3 after cardiac surgery
Characteristics Value*
Age (y) 63.97  14.99
Sex (male/female) 109 (66.9)/54 (33.1)
CABG 26 (16)
Valve surgery 44 (27)
Valve surgeryþCABG 22 (13.5)
Heart transplantation 34 (20.9)
Miscellaneousy 37 (22.7)
Duration of MV (d) 20.03  25.03
ICU length of stay (d) 23.19  25.41
Postoperative mortality (day 30) 53 (32.5)
In-hospital mortality 69 (42.3)
MV, Mechanical ventilation; CABG, coronary artery bypass graft. *Values are
expressed as means SD or n (%). yMiscellaneous cardiac surgery includes such pro-
cedures as repair of aortic dissection, repair of aneurysm rupture, and pericardiectomy.gery c October 2009
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MTABLE 2. Characteristics of the 163 studied patients according to weaning outcome on day 10 after cardiac surgery
Variables Successful weaning (n ¼ 50) Unsuccessful weaning* (n ¼ 113) P value
Preoperative
Age (y) 62.8  15.8y 64.5  14.7 .50
Male sex 34 (68) 75 (66.4) .83
Body mass index 26.3  17.4 24.9  22.5 .09
Charlson comorbidity index 2.2  1.9 2.6  2.2 .27
McCabe/Jackson score 3 40 (80) 90 (79.6) .96
NYHA class III–IV 31 (62) 68 (60.2) .83
Chronic respiratory failure 9 (18) 12 (10.6) .21
Chronic renal failure 1 (2) 6 (5.3) .67
Diabetes mellitus 3 (6) 12 (10.6) .55
LVEF<50% 29 (58) 53 (46.9) .19
EuroSCORE 7.4  4.7 7.4  3.3 .98
Emergency surgery 28 (56) 56 (50) .44
Intraoperative variables
Type of heart surgery
CABG surgery 9 (18) 17 (15) .63
Valve surgery 17 (34) 27 (24) .18
CABGþvalve surgery 4 (8) 18 (16) .17
Heart transplantation 12 (24) 22 (19) .51
Other heart surgery procedures 8 (16) 29 (26) .17
Duration of CPB (min) 107  49 119  62 .22
Aortic crossclamp time (min) 74  49 84  49 .2
Intra-aortic balloon pump 4 (8) 11 (9.7) .99
Postoperative ECMO 3 (6) 19 (16.8) .08
Troponin I day 2 (mg/L) 14.7  24.5 21  33.9 .28
Postoperative day 3
SAPS IIy 37.52  8.65 49.66  14.03 <.0001
SAPS II  45z 10 (20) 65 (57.5) <.0001
SOFAy 8.96  3.01 11.62  2.98 <.0001
Glasgow coma score<15 4 (8) 31 (27.4) .006
Lung injuryx 19 (38) 59 (52.2) .09
Epinephrine or norepinephrine 34 (68) 95 (84) .04
Urinary output<500 mL/24 h 1 (2) 27 (23.9) .0002
Arterial bicarbonates<2 0 mmol/L 22 (44) 91 (80.5) <.0001
Platelet count<100 3 109/L 19 (38) 66 (58.4) .02
Outcome measure
MV duration (d) 5.4  2.5 26.5  27.7 <.0001
ICU stay (d) 11.4  7.2 28.3  28.6 .0008
Hospital stay (d) 29.2  14.3 34.6  31.8 .25
In-hospital mortality 0 69 (61) <.0001
NYHA,New York Heart Association; LVEF, Left ventricular ejection fraction; EuroSCORE, European System for Cardiac Operative Risks Evaluation; CABG, coronary artery graft
bypass; CPB, cardiopulmonary bypass; ECMO, extracorporeal membrane oxygenation; SAPS, simplified acute physiology score; SOFA, sepsis-related organ failure score; MV,
mechanical ventilation; ICU, intensive care unit. *Defined as death or persistent mechanical ventilation on day 10 after cardiac surgery. yValues are expressed as means  SD or
(%). zCutoff value corresponding to the mean. xDefined as the combination of PaO2/FIO2 ratio<200 and presence of radiologic abnormalities in at least 2 quadrants.comorbidities. Our 6.2% rate of patients requiring MV for
more than 72 hours is close to the rates reported in other
recent series, ranging between 3.2% and 9.1%.3,21,22 This
group of very sick patients has considerably higher mortality
rates than patients rapidly weaned from MV. Thirty-day mor-
tality was 24% in a study by Murthy and associates22 and
was even higher in our patients (33%), although remaining
in the range of that predicted from SAPS II and SOFA scores
calculated on postoperative day 3. Thus, implementation of
specific strategies and interventions to improve the outcomes
of this specific subset of patients is urgently needed.The Journal of Thoracic and COur main objective when designing the present study was
to define an algorithm that might accurately select early on
postoperative day 3, patients who would be successfully
extubated by day 10. Indeed, while patients with high prob-
abilities of prolonged MV might benefit most from interven-
tions such as early tracheostomy, this type of procedure
might be at best useless or even sometimes dangerous in pa-
tients experiencing rapid and successful MV weaning. Sev-
eral studies have investigated factors associated with
prolonged MV after cardiac surgery.2-6,9,21-34 Serrano and
associates33 reported on a series of 569 patients undergoingardiovascular Surgery c Volume 138, Number 4 951
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MCABG surgery and tested the ability of the Intensive Care
Unit Risk Stratification Score (ICURSS) model to predict
prolonged MV. However, discrimination and calibration of
this scoring system, gathering only preoperative and imme-
diately postoperative variables, were poor. Alternatively,
Murthy and colleagues22 showed that hemodynamic status
on ICU admission (low cardiac output, vasopressor use, pul-
monary hypertension) and early postoperative events
(stroke, bacteremia) were more important than preoperative
and intraoperative variables in predicting ventilatory depen-
dency, defined as MV greater than 72 hours after cardiac
operation. A similar observation was reported by Kern and
colleagues,3 who found that only the postoperative measure
of severity of illness by the SAPS II and of the intensity of
treatment and nursing care activity by the Therapeutic Inter-
vention Scoring System (TISS) resulted in an effective
model for prediction of MV greater than 48 hours. Impor-
tantly, our objective differed significantly from these stud-
ies, inasmuch as we intended to predict ventilator weaning
within 10 postoperative days. Our data confirm that evolu-
tion of patients’ condition and response to treatment during
the first 3 days of MV provide more valuable prognostic in-
put than information collected preoperatively or on postop-
erative day 1. Furthermore, our simple algorithm might help
physicians decide which patients should be targeted for spe-
cific interventions aimed at reducing MV duration, such as
tracheostomy. Depending on the threshold chosen for this
scoring system, only 3% to 17% of the patients considered
at risk of long-term MV would have been tracheostomized
and weaned from MV before day 10 (false negative).
Indeed, tracheostomy has recognized advantages over
translaryngeal intubation, such as decreased airway resis-
tance, absence of oral–labial ulcerations, easier oral hygiene
TABLE 3. Multivariable logistic regression analysis: Factors
associated with postoperative day-10MV weaning success
Variables Odds ratio 95% CI P value
Urinary output  500 mL/24 h 16.47 1.87–145.09 .01
Glasgow coma score ¼ 15 9.75 2.49–38.23 .001
Arterial bicarbonates  20 mmol/L 6.09 2.54–14.57 <.0001
Platelets count 100 g/L 3.18 1.29–7.77 .01
No epinephrine or norepinephrine use 2.84 1.05–7.68 .04
No lung injury 2.40 1.01–5.70 .05
MV, Mechanical ventilation; CI, confidence intervals.952 The Journal of Thoracic and Cardiovascular Suror bronchopulmonary toilet, and improvement of airway
security. Moreover, our group10 has demonstrated that tra-
cheostomy led to less sedative administration, less time
spent heavily sedated, enhanced patient mobility, and ability
to be fed orally. We11 also reported on a large series of 506
patients requiring prolonged MV, of whom 166 were trache-
ostomized, that the intervention was associated with lower
ICU and in-hospital mortality rates. These observations led
us to design the Early percutaneous TracheOstomy for Car-
diac surgery (ETOC) trial (http://clinicaltrial.gov), a random-
ized study comparing early (day 4) versus late (after day 15)
tracheostomy for patients still requiring MV 3 days after car-
diac surgery, which is currently under way. However, since
the benefit of early tracheostomy for long-term postopera-
tive MV patients has not yet been proven, this procedure
cannot be systematically recommended for such patients.
Limitations of the Study
This study has several limitations. First, results of our
monocentric study may not be applicable to other centers
and the scoring system we designed should be prospectively
validated on other groups of patients from other institutions.
Indeed, our tertiary referral ICU routinely cares for severely
ill patients with terminal cardiac insufficiency, cardiogenic
shock, and emergencies like aortic dissection. As also re-
cently demonstrated by Filsoufi and associates,21 patients
undergoing complex operations such as aortic and combined
valveþCABG procedures are the most likely to experience
respiratory failure, defined as needing MV for more than
72 hours. Second, we included in our series 22 patients re-
quiring ECMO for refractory cardiogenic shock after cardiac
surgery and specifically after heart transplantation. How-
ever, these patients were still ventilator-dependent on post-
operative day 3, and although ECMO support lasted less
than 10 days on average, their mean duration of endotracheal
intubation was 31  28 days. Third, we may have missed
other important factors that may be associated with MV
weaning outcome. For example, our database does not con-
tain day-3 echocardiography findings, but use of catechol-
amine can be considered as a surrogate of cardiovascular
dysfunction. Ventilation parameters like tidal volume,
FIO2, and positive end-expiratory pressure were also not
included in our database, but PaO2/FIO2 ratio can beTABLE 4. Operational values of a score* to predict mechanical ventilation success on day 10 after cardiac surgery
Likelihood ratio
Point threshold Sensitivity (%) Specificity (%) PPV (%) NPV (%) Positive (95% CI) Negative (95% CI)
8 58 91 74 83 6.56 (3.64–12.05) 0.46 (0.36–0.60)
7 74 79 61 87 3.48 (2.43–4.76) 0.33 (0.21–0.50)
6 94 51 46 95 1.93 (1.62–2.09) 0.12 (0.04–0.32)
5 98 27 37 97 1.33 (1.18–1.37) 0.08 (0.01–0.40)
PPV, Positive predictive value; NPV, negative predictive value; CI, confidence intervals. *Score based on six independent variables: urinary output, Glasgow coma score, arterial
bicarbonates, platelets count; epinephrine or norepinephrine, and lung injury (Table 3).gery c October 2009
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Mconsidered as a relevant marker of respiratory status. Last,
inasmuch as the main purpose of this scoring system was
to help physicians avoid performing a needless tracheos-
tomy in patients rapidly weaned, we defined the MV wean-
ing-failure group as patients either deceased or still requiring
MV by postoperative day 10, potentially leading to tracheos-
tomizing patients who would die shortly after the procedure.
However, because this intervention might have an impact
both on survival and on MV duration, such a composite
end point might be fully appropriate, as also recently under-
lined by Gajic and associates.35
In summary, patients still requiring MV on day 3 after car-
diac surgery had poor outcomes. Only 30% were success-
fully weaned on postoperative day 10. Specific strategies
aimed at reducing MV duration and related complications
should be tested to improve the outcomes of this subset of
critically ill patients. The simple score we propose herein
might help physicians better identify patients with a strong
likelihood of rapid and successful MV weaning, to avoid
needless and potentially hazardous interventions, such as
early percutaneous tracheostomy. For other patients, trache-
ostomy might be an option, since, to date, equipoise exists
regarding performing or not this procedure.
We thank Agne`s Gaubert for data collection and excellent tech-
nical assistance.
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